| dc.description.abstract | Cardiovascular diseases are among the leading causes of death worldwide and
particularly in the developed World. The search for new therapeutic approaches for
improving the functions of the damaged heart is therefore a critical endeavour.
Myocardial infarction, which can lead to heart failure, is associated with irreversible loss of functional cardiomyocytes. The loss of cardiomyocytes poses a major difficulty for treating the damaged heart since terminally differentiated cardiomyocytes have very
limited regeneration potential. Currently, the only effective treatment for severe heart
failure is heart transplantation but this option is limited by the acute shortage of donor hearts. The high incidence of heart diseases and the scarcity donor hearts underline the urgent need to find alternative therapeutic approaches for treating cardiovascular diseases.
Pluripotent embryonic stem (ES) cells can differentiate into functional cardiomyocytes.
Therefore the engraftment of ES cell-derived functional cardiomyocytes or cardiac
progenitor cells into the damaged heart to regenerate healthy myocardial tissues may
be used to treat damaged hearts. Stem cell-based therapy therefore holds a great
potential as a very attractive alternative to heart transplant for treating heart failure and other cardiovascular diseases. A major obstacle to the realisation of stem cell-based therapy is the lack of donor cells and this in turn is due to the fact that, currently, the molecular mechanisms or the regulatory signal transduction mechanisms that are responsible for mediating ES cell differentiation into cardiomyocytes are not well understood. Overcoming this huge scientific challenge is absolutely necessary before the use of stem cell-derived cardiomyocytes to treat the damaged heart can become a reality.
Therefore the aim of this thesis was to investigate the signal transduction pathways that are involved in the differentiation of stem cells into cardiomyocytes. The first objective was the establishment and use of cardiomyocyte differentiation models using H9c2 cells and P19 stem cells to accomplish the specific objectives of the thesis. The specific objectives of the thesis were, the investigation of the roles of (i) nitric oxide (ii) protein kinase C (PKC), (iii) p38 mitogen-activated protein kinase (p38 MAPK) (vi) phosphoinositide 3-kinase (PI3K) and (vi) nuclear factor-kappa B (NF-kB) signalling pathways in the differentiation of stem cells to cardiomyocytes and, more importantly, to identify where possible any points of convergence and potential cross-talk between pathways that may be critical for differentiation to occur.
P19 cells were routinely cultured in alpha minimal essential medium (α-MEM)
supplemented with 100 units/ml penicillin /100 μg/ml streptomycin and 10% foetal bovine serum (FBS). P19 cell differentiation was initiated by culturing the cells in microbiological plates in medium containing 0.8 % DMSO to form embryoid bodies (EB).
This was followed by transfer of EBs to cell culture grade dishes after four days.
H9c2 cells were cultured in Dulbecco’s Modified Eagle’s medium (DMEM)
supplemented with 10% FBS. Differentiation was initiated by incubating the cells in
medium containing 1% FBS.
In both models, when drugs were employed, they were added to cells for one hour prior
to initiating differentiation. Cell monolayers were monitored daily over a period of 12 or 14 days. H9c2 cells were monitored for morphological changes and P19 cells were monitored for beating cardiomyocytes. Lysates were generated in parallel for western blot analysis of changes in cardiac myosin heavy chain (MHC), ventricular myosin chain light chain 1(MLC-1v) or troponin I (cTnI) using specific monoclonal antibodies. H9c2 cells cultured in 1% serum underwent differentiation as shown by the timedependent formation of myotubes, accompanied by a parallel increase in expression of both MHC and MLC-1v. These changes were however not apparent until 4 to 6 days after growth arrest and increased with time, reaching a peak at day 12 to 14. P19 stem cells cultured in DMSO containing medium differentiated as shown by the timedependent appearance of beating cardiomyocytes and this was accompanied by the expression of cTnI.
The differentiation of both P19 stem cells and H9c2 into cardiomyocytes was blocked by
the PI3K inhibitor LY294002, PKC inhibitor BIM-I and the p38 MAPK inhibitor
SB2035800. However when LY294002, BIM-I or SB2035800 were added after the
initiation of DMSO-induced P19 stem cell differentiation, each inhibitor failed to block the cell differentiation into beating cardiomyocytes. The NF-kB activation inhibitor, CAPE, blocked H9c2 cell differentiation into cardiomyocytes. Fast nitric oxide releasing donors (SIN-1 and NOC-5) markedly delayed the onset of differentiation of H9c2 cells into cardiomyocytes while slow nitric oxide releasing donors (SNAP and NOC-18) were
less effective in delaying the onset of differentiation or long term differentiation of H9c2 cells into cardiomyocytes. Akt (protein kinase B) is the key downstream target of PI3K.
Our cross-talk data also showed that PKC inhibition and p38 MAPK inhibition
respectively enhanced and reduced the activation of Akt, as determined by the
phosphorylation of Akt at serine residue 473.
In conclusion, PKC, PI3K, p38 MAPK and NF-kB are relevant for the differentiation of
stem cells into cardiomyocytes. Our data also show that the PKC, PI3K and p38 MAPK
signalling pathways are activated as very early events during the differentiation of stem cells into cardiomyocytes. Our data also suggest that PKC may negatively regulate Akt activation while p38 MAPK inhibition inhibits Akt activation. Our fast NO releasing donor data suggest that nitric oxide may negatively regulate H9c2 cell differentiation. | en |
